C FRANK BENNETT
CIK 1073387 · EVP, Chief Scientific Officer · last filed 2026-07-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.00M
Companies
2
Total Filings
142
Lifetime Open-Market Net
-$38.97M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | EVP, Chief Scientific Officer | 75,018 | $53.28 | $4.00M | -$31.71M | 71 | 2026-07-09 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | SVP, Antisense Research | 11,225 | — | — | -$7.26M | 54 | 2015-12-17 |
Recent Filings · Page 10 of 15
142 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-11-09 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$207.7K | EDGAR |
| 2015-07-02 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Other (J) | +87 | $4.2K | EDGAR |
| 2015-03-25 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$842.1K | EDGAR |
| 2015-01-20 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +2,466 | -$103.2K | EDGAR |
| 2015-01-05 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +136 | $4.1K | EDGAR |
| 2014-08-28 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | −2,000 | -$156.5K | EDGAR |
| 2014-07-01 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Other (J) | +291 | $8.8K | EDGAR |
| 2014-01-17 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +1,306 | -$37.9K | EDGAR |
| 2014-01-03 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +164 | $4.0K | EDGAR |
| 2013-12-06 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$245.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.